1. Home
  2. IDYA vs WRBY Comparison

IDYA vs WRBY Comparison

Compare IDYA & WRBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

N/A

Current Price

$35.87

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

N/A

Current Price

$27.59

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IDYA
WRBY
Founded
2015
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.1B
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
IDYA
WRBY
Price
$35.87
$27.59
Analyst Decision
Strong Buy
Buy
Analyst Count
16
11
Target Price
$52.86
$27.10
AVG Volume (30 Days)
1.4M
3.4M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
105.88
EPS
N/A
0.03
Revenue
$218,710,000.00
$871,905,000.00
Revenue This Year
N/A
$14.48
Revenue Next Year
$201.05
$16.41
P/E Ratio
N/A
$916.67
Revenue Growth
3024.43
13.04
52 Week Low
$21.33
$14.96
52 Week High
$40.58
$31.00

Technical Indicators

Market Signals
Indicator
IDYA
WRBY
Relative Strength Index (RSI) 50.34 45.63
Support Level $32.85 $26.25
Resistance Level $38.17 $27.59
Average True Range (ATR) 1.45 1.44
MACD -0.47 -0.31
Stochastic Oscillator 4.70 6.09

Price Performance

Historical Comparison
IDYA
WRBY

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The Company provides holistic vision care by offering eyewear, contacts, and eye care directly to consumers through its integrated, omnichannel platform. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

Share on Social Networks: